ipilimumab,nivolumab,cabozantinib
exelixis,bms
['cosmic-313']
majestic presentation of the phase 3 cosmic-313 study by at the presidential symposium #esmo22 towards better outcomes for patients with #kidneycancer 
Postdoctoral GU Oncology Research Fellow @DanaFarber | MD, Class of 2020 @USJLiban | Interested in Oncology